Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2707–2713. doi: 10.1158/1055-9965.EPI-08-0232

Table 1.

Characteristics of patients with esophageal cancer, Columbia University and Weill Cornell Medical Centers.

Total No. (%)
Columbia
Cornell p-value*
Number of patients 354 (100%) 197 (56%) 157 (44%)
Mean age, years (S.D.) 63.8 (12.0) 66.2 (11.7) 60.8 (11.8) <0.0001
Male sex 270 (76%) 140 (71%) 130 (83%) 0.01
Smokers (ever) <0.001
 Never 106 (30%) 33 (17%) 73 (46%)
 Ever 183 (52%) 99 (50%) 84 (53%)
 Unknown 65 (18%) 65 (33%) 0 (0%)
Race/ethnicity <0.001
 White 260 (74%) 117 (59%) 143 (92%)
 Black 33 (9%) 25 (13%) 8 (5%)
 Hispanic 33 (9%) 33 (17%) 0 (0%)
 Other 27 (8%) 22 (11%) 5 (3%)
Tumor histology 0.19
 Adenocarcinoma 201 (57%) 104 (53%) 97 (62%)
 Squamous cell 131 (37%) 81 (41%) 50 (32%)
 Other 22 (7%) 12 (6%) 10 (6%)
Tumor subsite 0.05
 GE junction 65 (19%) 41 (21%) 24 (16%)
 Lower esophagus 182 (52%) 94 (48%) 88 (58%)
 Mid-esophagus 71 (20%) 38 (19%) 33 (22%)
 Upper esophagus 32 (9%) 24 (12%) 8 (5%)
Site of metastasis
 Lung 53 (15%) 28 (14%) 25 (16%) 0.66
 Liver 56 (16%) 20 (10%) 36 (23%) <0.001
 Other 86 (24%) 32 (16%) 54 (34%) <0.001
Stage at diagnosis
 1-3 330 (93%) 173 (88%) 157 (100%) <0.001
 4 24 (7%) 24 (12%) 0 (0%)
*

For comparison between Columbia and Cornell study sites.

Some subjects had multiple sites of metastasis.